Will Buntanetap from Annovis Bio receive FDA approval before 2028?
Basic
9
Ṁ625
2028
13%
chance

The drug is in phase 3 trials now for Parkinson's Disease and Alzheimer's Disease.

AKA Posiphen or ANVS401

Study link here: https://clinicaltrials.gov/ct2/show/NCT05357989

Get
Ṁ1,000
and
S3.00
Sort by:

Stock +40% over the past month. Does the market know something we/I don't?

I have only skimmed information on this but the base rate for drugs actually working for Alzheimer's etc is really low. It may be approved anyway (e.g. aducanumab) though.

© Manifold Markets, Inc.Terms + Mana-only TermsPrivacyRules